Identification of rare sequence variation underlying heritable pulmonary arterial hypertensionStefan Gräf, Nicholas W. Morrell, Dan F. Stein et al.|Nature Communications|2018Cited by 382
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J. Rhodes, Martin R. Wilkins, Pavandeep Ghataorhe et al.|Circulation|2016Cited by 214
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Taco W. Kuijpers, Marta Bleda et al.|Circulation|2017Cited by 144
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertensionMark Toshner, Paul A. Corris, Colin Church et al.|European Respiratory Journal|2021Cited by 89
Defining the clinical validity of genes reported to cause pulmonary arterial hypertensionCarrie L. Welch, David Langleben, Micheala A. Aldred et al.|Genetics in Medicine|2023Cited by 73